Pipeline Health | Cerner
Pipeline Health | Cerner
Pipeline Health | Cerner
St. Joseph's Health - Clients | Cerner
In this comprehensive Chilmark report, read what HCO and their associated physicians and other healthcare providers need in the handling of healthcare data, and how current developments aid in higher returns on an EHR investment and aid in patient satisfaction.
Robert Pierce, MD, MSPH, FAAFP, DABPM-CI, associate professor of family and community medicine and medical director of clinical decision support for University of Missouri Health Care, shares how his organization is contributing to the development of the seamless exchange of data and lessons learned along the way.
https://www.cerner.com/simplify/value-of-seamless-exchange-webinar
View the video Seamless Exchange: New tool to simplify data exchange to see how Cerner Seamless Exchange incorporates data into a single longitudinal record across a variety of care venues and disparate EHR systems.
https://www.cerner.com/simplify/seamless-exchange-a-sample-case-demo-video
Seamless Exchange™ is a new interoperability solution which is targeted to be generally available in 2021. This new solution is designed to help enhance the clinician’s workflow and facilitate a comprehensive longitudinal record for the patient.
https://www.cerner.com/simplify/advancing-interoperability-with-seamless-exchange-webinar
Join Sam Lambson, VP of interoperability, and Jeremy Davis, senior director, as they provide an overview of Cerner Unite™, our vision for a comprehensive approach to interoperability.
To help physicians spend more time with their patients and less time searching for data, Seamless Exchange™ is designed to help provide a comprehensive patient record.
https://www.cerner.com/simplify/reaching-true-interoperable-healthcare-records
View the video Seamless Exchange: New tool to simplify data exchange to see how Cerner Seamless Exchange incorporates data into a single longitudinal record across a variety of care venues and disparate EHR systems.
https://www.cerner.com/simplify/seamless-exchange-overview-video-vignette
Archive - Perspectives | Cerner
https://www.cerner.com/perspectives/archive
AwardsOpioid use disorder and health service utilization among COVID-19 patients in the US: A nationwide cohort from the Cerner Real-World Data
Pregnant women are potentially a high-risk population during infectious disease outbreaks such as COVID-19, because of physiologic immune suppression in pregnancy. However, data on the morbidity and mortality of COVID-19 among pregnant women, compared to nonpregnant women, are sparse and inconclusive. We sought to assess the impact of pregnancy on COVID-19 associated morbidity and mortality, with particular attention to the impact of pre-existing comorbidity.
https://www.cerner.com/rwd-publications/retrospective-analysis-of-pregnant-women-with-covid-19
Numerous drugs are currently under accelerated clinical investigation for the treatment of coronavirus disease 2019 (COVID‐19); however, well‐established safety and efficacy data for these drugs are limited. The goal of this study was to predict the potential of 25 small molecule drugs in clinical trials for COVID‐19 to cause clinically relevant drug‐drug interactions (DDIs), which could lead to potential adverse drug reactions (ADRs) with the use of concomitant medications.
https://www.cerner.com/rwd-publications/predicting-interactions-of-drugs-in-covid-19-clinical-trials
Racial disparities in COVID-19 outcomes exist despite comparable Elixhauser comorbidity indices between Blacks, Hispanics, Native Americans, and Whites. Factors contributing to racial inequities in outcomes from coronavirus disease 2019 (COVID-19) remain poorly understood. We compared by race the risk of 4 COVID-19 health outcomes––maximum length of hospital stay (LOS), invasive ventilation, hospitalization exceeding 24 h, and death––stratified by Elixhauser comorbidity index (ECI) ranking. Outcomes and ECI scores were constructed from retrospective data obtained from the Cerner COVID-19 De-Identified Data cohort.
https://www.cerner.com/rwd-publications/racial-disparities-in-covid-19-outcomes
At the population level, Black and Hispanic adults in the United States have increased risk of dying from COVID-19, yet whether race and ethnicity impact on risk of mortality among those hospitalized for COVID-19 is unclear.
https://www.cerner.com/rwd-publications/impact-of-race-and-ethnicity-on-covid-19-adult-patients
Since the introduction of remdesivir and dexamethasone for severe COVID-19 treatment, few large multi-hospital system US studies have described clinical characteristics and outcomes of minority COVID-19 patients who present to the emergency department (ED).
Cytokine storm syndrome in patients with COVID-19 is mediated by pro-inflammatory cytokines resulting in acute lung injury and multiorgan failure. Elevation in serum ferritin and D-dimer is observed in COVID-19 patients. To determine prognostic values of optimal serum cutoff with trajectory plots for both serum ferritin and D-dimer in COVID-19 patients with invasive ventilator dependence and in-hospital mortality.